SENORES PHARMACEUTICALS L Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

SENORES PHARMACEUTICALS L cash flow conversion efficiency. Based on the latest financial reports, SENORES PHARMACEUTICALS L (SENORES) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs242.20 Million ≈ $2.62 Million USD) by net assets (Rs8.34 Billion ≈ $90.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of SENORES PHARMACEUTICALS L (2022–2026)

Cash flow conversion efficiency of SENORES PHARMACEUTICALS L from 2022 to 2026. This chart illustrates how SENORES PHARMACEUTICALS L's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for SENORES PHARMACEUTICALS L for real-time trading data and today's change.

SENORES PHARMACEUTICALS L Cash Flow Conversion Ratio Explained

SENORES PHARMACEUTICALS L cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

SENORES PHARMACEUTICALS L Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SENORES PHARMACEUTICALS L ranked by their cash flow conversion efficiency. Also see SENORES market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Rashi Peripherals Limited NSE:RPTECH	0.017x
Zhejiang Meili High Technology Co Ltd SHE:300611	0.062x
Jilin Liyuan Precision Manufacturing Co Ltd SHE:002501	-0.165x
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT JK:LSIP	0.019x
Hanwha Investment&Securities Co Ltd KO:003530	-0.108x
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	0.027x
ZJAMP Group Co Ltd SHE:002758	0.073x
Cuckoo Electronics Co Ltd KO:192400	0.022x

Annual Cash Flow Conversion Efficiency for SENORES PHARMACEUTICALS L (2022–2026)

The table below shows the annual cash flow conversion efficiency of SENORES PHARMACEUTICALS L from 2022 to 2026. Review SENORES FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs9.65 Billion ≈ $104.31 Million	Rs620.50 Million ≈ $6.71 Million	0.064x	+101.33%
2025-03-31	Rs94.96 Million ≈ $1.03 Million	Rs-459.20 Million ≈ $-4.97 Million	-4.836x	-4260.01%
2024-03-31	Rs2.32 Billion ≈ $25.06 Million	Rs-257.00 Million ≈ $-2.78 Million	-0.111x	-367.70%
2023-03-31	Rs454.99 Million ≈ $4.92 Million	Rs-10.79 Million ≈ $-116.69K	-0.024x	+91.69%
2022-03-31	Rs365.90 Million ≈ $3.96 Million	Rs-104.47 Million ≈ $-1.13 Million	-0.286x	--

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$571.27 Million

Rs52.82 Billion INR

Market Cap Rank

#11194 Global

#563 in India

Share Price

Rs1147.00

Change (1 day)

+2.45%

52-Week Range

Rs710.25 - Rs1550.90

All Time High

Rs1550.90